Cargando…

Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1

Ras-related C3 botulinum toxin substrate 1 (Rac1) functions as a molecular switch by cycling between an inactive guanosine diphosphate (GDP)–bound state and an active guanosine triphosphate (GTP)–bound state. An oncogenic mutant of Rac1, an N92I mutant, strongly promotes cell proliferation and subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyama, Yuki, Kontani, Kenji, Katada, Toshiaki, Shimada, Ichio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685717/
https://www.ncbi.nlm.nih.gov/pubmed/31457101
http://dx.doi.org/10.1126/sciadv.aax1595
_version_ 1783442448711680000
author Toyama, Yuki
Kontani, Kenji
Katada, Toshiaki
Shimada, Ichio
author_facet Toyama, Yuki
Kontani, Kenji
Katada, Toshiaki
Shimada, Ichio
author_sort Toyama, Yuki
collection PubMed
description Ras-related C3 botulinum toxin substrate 1 (Rac1) functions as a molecular switch by cycling between an inactive guanosine diphosphate (GDP)–bound state and an active guanosine triphosphate (GTP)–bound state. An oncogenic mutant of Rac1, an N92I mutant, strongly promotes cell proliferation and subsequent oncogenic activities by facilitating the intrinsic GDP dissociation in the inactive GDP-bound state. Here, we used solution nuclear magnetic resonance spectroscopy to investigate the activation mechanism of the N92I mutant. We found that the static structure of the GDP binding site is not markedly perturbed by the mutation, but the overall conformational stability decreases in the N92I mutant, which then facilitates GDP dissociation by lowering the activation energy for the dissociation reaction. On the basis of these results, we proposed the activation mechanism of the N92I mutant, in which the decreased conformational stability plays important roles in its activation process.
format Online
Article
Text
id pubmed-6685717
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-66857172019-08-27 Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1 Toyama, Yuki Kontani, Kenji Katada, Toshiaki Shimada, Ichio Sci Adv Research Articles Ras-related C3 botulinum toxin substrate 1 (Rac1) functions as a molecular switch by cycling between an inactive guanosine diphosphate (GDP)–bound state and an active guanosine triphosphate (GTP)–bound state. An oncogenic mutant of Rac1, an N92I mutant, strongly promotes cell proliferation and subsequent oncogenic activities by facilitating the intrinsic GDP dissociation in the inactive GDP-bound state. Here, we used solution nuclear magnetic resonance spectroscopy to investigate the activation mechanism of the N92I mutant. We found that the static structure of the GDP binding site is not markedly perturbed by the mutation, but the overall conformational stability decreases in the N92I mutant, which then facilitates GDP dissociation by lowering the activation energy for the dissociation reaction. On the basis of these results, we proposed the activation mechanism of the N92I mutant, in which the decreased conformational stability plays important roles in its activation process. American Association for the Advancement of Science 2019-08-07 /pmc/articles/PMC6685717/ /pubmed/31457101 http://dx.doi.org/10.1126/sciadv.aax1595 Text en Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (http://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Toyama, Yuki
Kontani, Kenji
Katada, Toshiaki
Shimada, Ichio
Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
title Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
title_full Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
title_fullStr Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
title_full_unstemmed Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
title_short Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
title_sort decreased conformational stability in the oncogenic n92i mutant of ras-related c3 botulinum toxin substrate 1
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685717/
https://www.ncbi.nlm.nih.gov/pubmed/31457101
http://dx.doi.org/10.1126/sciadv.aax1595
work_keys_str_mv AT toyamayuki decreasedconformationalstabilityintheoncogenicn92imutantofrasrelatedc3botulinumtoxinsubstrate1
AT kontanikenji decreasedconformationalstabilityintheoncogenicn92imutantofrasrelatedc3botulinumtoxinsubstrate1
AT katadatoshiaki decreasedconformationalstabilityintheoncogenicn92imutantofrasrelatedc3botulinumtoxinsubstrate1
AT shimadaichio decreasedconformationalstabilityintheoncogenicn92imutantofrasrelatedc3botulinumtoxinsubstrate1